Sellas Life Sciences SLS 深 滬
等待開盤 10-08 09:30:00 美东时间
11.31
-0.030
-0.26%
華盛通- 最 高11.54
- 今 開11.28
- 成交量 313.54万股
- 最 低 11.1451
- 昨 收 11.34
- 總市值 22.84亿
- 52周最高 15.8765
- 市盈率 靜 --
- 換手率 1.55%
- 52周最低 1.39
- 委 比 86.39%
- 總股本 2.02亿
- 歷史最高 554.50
- 量 比 0.58
- 振 幅 3.48%
- 歷史最低 0.4986
- 每 手 1
- 風險率 4.20%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer
SELLAS Life Sciences Group announced preclinical data showing that its CDK9 inhibitor, SLS009, demonstrated significant anti-tumor activity in MYC-amplified pancreatic ductal adenocarcinoma (PDAC) models, including a daraxonrasib-resistant model. SLS009 induced higher apoptosis and necrosis compared to daraxonrasib alone and further enhanced cancer cell death when combined with daraxonrasib. Additionally, SLS009 combined with the BET inhibitor ZE...
09-25 17:00
When Revolution Medicines' FDA Win Lifts Other Boats: SELLAS Life Sciences Stock Surges
SELLAS Life Sciences Group Inc. (NASDAQ:SLS) stock is trading higher on Thursday. Year-to-date, the stock has surged by around 300%. FDA Approval Catalyst For Pancreatic Cancer SLS’s momentum on Thursday may be related to the U.S. Food and Drug Administration (FDA) on Wednesday approving Revolution ...
08-28 01:13
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often look for circumstances when the market estimation of an option diverges away fro...
08-19 01:35
SELLAS Life Sciences Gr Q2 EPS $(0.05) Misses $(0.04) Estimate
SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.04) by 25 percent. This is a 28.57 percent increase over losses of $(0.07) per share from the same period last year.
08-12 04:19
SELLAS Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update
SELLAS Life Sciences Group reported Q2 2026 financial results, advancing its lead programs GPS and SLS009 in acute myeloid leukemia (AML). The Phase 3 REGAL trial for GPS is nearing its 80th event, a key milestone for final efficacy analysis. SLS009 has enrolled 28 patients in its Phase 2 AML trial, with topline data expected in Q4 2026. Preclinical data shows potential for SLS009 in pancreatic cancer resistant to RAS inhibitors. Cash and cash eq...
08-11 20:05
期权扫描 | 美光连跌四日！多张末日PUT单飙涨逾170%；SoFi期权成交放量至80万张
美光科技连跌四日！多张末日PUT单飙涨逾170%；SoFi绩后重挫近9%，期权成交放量至80万张，热门Call单押注超跌反弹>>
07-30 19:45
SELLAS Life Sciences Faces Adverse Arbitration Ruling
SELLAS Life Sciences Group ( ($SLS) ) has issued an update. On July 24, 2026, a...
07-28 04:58
3D prevails in arbitration against Sellas, awarded $1M in costs
3D Medicines said it has won an arbitration case against Sellas Life Sciences Group (SLS), with an arbitrator dismissing all of Sellas's claims and ordering the U.S. biotechnology company to reimburse...
07-28 01:57
ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Nasdaq Composite falling around 400 points on Friday. Shares of ManpowerGroup Inc (NYSE:MAN) rose sharply after the company reported upbeat second-quarter results and issued third-quarter earnings guidance above expectations. Adjusted earnings were 99 cents per share...
07-17 22:09
SELLAS Life Sciences Shares Slip Wednesday as Price Tests $16 Resistance Wall
SELLAS Life Sciences Group Inc (NASDAQ:SLS) shares are trading lower Wednesday as investors take profits following the stock’s strong longer-term uptrend, with broader risk appetite also softer across equities. SELLAS Life Sciences shares are volatile Wednesday. Why is SLS stock down today? Critical...
07-08 23:09
